This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Biography of Vadim Markovtosov
Introduction
Vadim Markovtosov is an accomplished inventor based in Foster City, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit JAK kinases.
Latest Patents
Vadim holds two patents, with his latest invention focusing on Pyrimidine-2-amine compounds. These compounds are designed to serve as inhibitors of JAK kinases, which are crucial in treating diseases associated with JAK2 activity. The invention includes pharmaceutical compositions comprising these compounds and methods for their use in medical treatments.
Career Highlights
Vadim is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to innovate and contribute to the pharmaceutical industry. His work has been pivotal in advancing therapeutic options for various medical conditions.
Collaborations
Throughout his career, Vadim has collaborated with notable colleagues, including Somasekhar Bhamidipati and Jeffrey Clough. These partnerships have enhanced the research and development efforts within his field.
Conclusion
Vadim Markovtosov's contributions to the field of pharmaceuticals through his inventions and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the development of new treatments for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile